Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations

Autor: A Veral, Suna Cokmert, O Sivrikoz, SD Kececi, N Akyurek, U Coskun, E Yilmaz, O Tanriverdi

The concomitant epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) translocations in lung adenocancers are very rare scenarios. Until now, 42 cases described in the literature have all been treated by different drug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18c5bedf5e96f5887e0f27b205a8411
https://hdl.handle.net/11454/79066

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Coexistence of Ankylosing Spondylitis and Löfgren's Syndrome.

Autor: Kobak S; Department of Rheumatology, Faculty of Medicine, Sifa University, 35100 Bornova, Izmir, Turkey., Sever F; Department of Chest Diseases, Faculty of Medicine, Sifa University, 35100 Bornova, Izmir, Turkey., Sivrikoz O; Department of Pathology, Faculty of Medicine, Sifa University, 35100 Bornova, Izmir, Turkey., Karaarslan A; Department of Orthopedics, Faculty of Medicine, Sifa University, 35100 Bornova, Izmir, Turkey.

Publikováno v: Case reports in rheumatology [Case Rep Rheumatol] 2014; Vol. 2014, pp. 747698. Date of Electronic Publication: 2014 Mar 11.